Pancreatic Cancer Research

ResearcherErasmus MCActive in the last 2 years

Kasper A. Overbeek

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1829-9963; OpenAlex author ID A5068004770. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
64
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: 1 paper

Papers 8

  1. Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery. Co-author DOI 10.1097/sla.0000000000006094↗
  2. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Co-author DOI 10.1016/j.pan.2022.03.021↗
  3. Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals. Co-author DOI 10.1053/j.gastro.2021.10.014↗
  4. Long-term yield of pancreatic cancer surveillance in high-risk individuals. Co-author DOI 10.1136/gutjnl-2020-323611↗
  5. Genotype-phenotype correlations for pancreatic cancer risk in Dutch melanoma families with pathogenic CDKN2A variants. Co-author DOI 10.1136/jmedgenet-2019-106562↗
  6. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance. First author DOI 10.1007/s10689-020-00171-8↗
  7. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAP… First author DOI 10.1136/gutjnl-2019-319352↗
  8. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas scr… First author DOI 10.1136/gutjnl-2019-319352corr1↗

Closest collaborators

The 25 strongest of 64 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marco J. Bruno · 7 shared papers, 2020–2022 · strength 0.71
  2. Djuna L. Cahen · 7 shared papers, 2020–2022 · strength 0.71
  3. Jeanin Elise van Hooft · 5 shared papers, 2020–2022 · strength 0.47
  4. Michael Goggins · 4 shared papers, 2020–2024 · strength 0.43
  5. Hans F. A. Vasen · 4 shared papers, 2020–2022 · strength 0.40
  6. Brechtje D.M. Koopmann · 3 shared papers, 2022 · strength 0.35
  7. Iris J. M. Levink · 3 shared papers, 2022 · strength 0.35
  8. Diane M. Simeone · 3 shared papers, 2020–2024 · strength 0.32
  9. Ingrid C. A. W. Konings · 3 shared papers, 2020–2022 · strength 0.31
  10. Salvatore Paiella · 2 shared papers, 2022–2024 · strength 0.27
  11. Marcia Irene Canto · 3 shared papers, 2020–2022 · strength 0.26
  12. Detlef Klaus Bartsch · 3 shared papers, 2020–2022 · strength 0.26
  13. Randall E. Brand · 3 shared papers, 2020–2022 · strength 0.26
  14. Sapna Syngal · 3 shared papers, 2020–2022 · strength 0.26
  15. Aimee Lee Lucas · 3 shared papers, 2020–2022 · strength 0.26
  16. Thomas Mathias Gress · 3 shared papers, 2020–2022 · strength 0.26
  17. Elena M. Stoffel · 3 shared papers, 2020–2022 · strength 0.26
  18. Fay Kastrinos · 3 shared papers, 2020–2022 · strength 0.26
  19. Claudio Bassi · 2 shared papers, 2020–2024 · strength 0.24
  20. James J. Farrell · 2 shared papers, 2020–2024 · strength 0.24
  21. Bas Groot Koerkamp · 2 shared papers, 2020–2022 · strength 0.21
  22. Femme Harinck · 2 shared papers, 2020–2022 · strength 0.21
  23. Marc G. Besselink · 2 shared papers, 2020–2022 · strength 0.21
  24. Casper H.J. van Eijck · 2 shared papers, 2020–2022 · strength 0.21
  25. Alfredo Carrato Mena · 2 shared papers, 2020–2022 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.